
seen from South Africa
seen from United States

seen from United States

seen from United States

seen from Czechia
seen from United States
seen from United States

seen from United States
seen from Malaysia
seen from Russia
seen from United States

seen from United States

seen from Türkiye
seen from Spain
seen from Malaysia

seen from United States
seen from China

seen from China

seen from United States

seen from Italy
Use Sales Copilot to see the leads and opportunities assigned (Dynamics 365)
Using the “Sales Copilot” we can get the list of leads and opportunities assigned to us in the last 15 days. For this, we can use the “What’s newly assigned to me” prompt To enable Sales Copilot, Inside Sales Hub, navigate to App Settings >> Copilot (General Settings) and specify the Sales Apps in which we want the Sales Copilot to be enabled. To see it in action, open the Sales Copilot Help…
View On WordPress
Deploy Web Resources and Plugin directly from Visual Studio using Kupp Code Analytics
In the previous posts, we covered the Overview and Key Features of Kupp Code Analytics, the installation and setup process of the extension, its Intellisense capabilities, and the analytics capabilities. In this blog post, we will cover deploying Web Resources and Plugin directly from Visual Studio using the Kupp Code Analytics extension, which makes the process more efficient and less…
View On WordPress
01.02 9E005D — 1A1A1A
the internet needs to stop using white on pure black as a color scheme
Bohai Pharmaceuticals Updates Corporate Website
Yantai, China, via ETELIGIS INC., 07/29/2014 - - Bohai Pharmaceuticals Group, Inc. (OTCQB: BOPH), a leading manufacturer and marketer of traditional Chinese medicine (TCM), today said it has updated its company website to include new corporate and industry information.
Bohai’s main site, http://www.bohaipharma.com, also includes a new investor relations section, http://irdirect.net/BOPH/corporate_overview, which features expanded information and news on the company, its products and markets.
The updated site was edited by Bohai’s investor/public relations agency, New York-based Asia IR-PR, which specializes in representing U.S.-listed Chinese public companies to the worldwide financial community.
"We are very excited about our new website," said Bohai chairman and chief executive officer, Mr. Hongwei Qu. "Bohai has been making substantial progress marketing some of our industry's most popular TCMs – including two on China’s Essential Drug List – and we look forward to communicating this progress to our worldwide investors."
Investors wishing to receive Bohai’s corporate communications as they become available may go to http://irdirect.net/BOPH/email_alerts and register under Email Alerts.
Additional information on Bohai may also be found at http://asia-irpr.com/clients/bohai/ and at the company’s featured page on the worldwide investor platform, Company Spotlight: http://www.companyspotlight.com/114569/bohai-pharmaceuticals-group-inc .
Bohai Pharmaceuticals Group
A manufacturer and marketer of traditional Chinese medicine (TCM) in the People’s Republic of China, Bohai offers seven varieties of approved herbal medicines comprising four prescription drugs and three over-the-counter products in six delivery systems. The company reported net income of $19.1 million on revenue of $151.8 million for the year ended June 30, 2013.
Asia IR-PR http://asia-irpr.com/
Founded in 2013, Asia IR-PR is a full-service IR/PR/Media company formed specifically to develop comprehensive communications programs for Asia-based public companies listed on NASDAQ, NYSE, and the HKSE. The principals of Asia IR-PR, with decades of experience in the public markets, have managed and successfully conducted both IR and PR campaigns for over 100 U.S.-listed companies. Based in New York City, Asia IR-PR has in-house analysts and executives fluent in both Mandarin and English in order to best communicate with Chinese management of our listed client companies.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of United States securities laws. You should not rely upon forward-looking statements as predictions of future events. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or to changes in our expectations. You should review the factors described in the section entitled "Risk Factors" in our prospectus filed with the SEC and other documents we file from time to time with the SEC. We qualify all of our forward-looking statements by these cautionary statements.
Contacts:
Investors
Jimmy Caplan
Asia IR/PR
512-329-9505
Media
Rick Eisenberg
Asia IR/PR
212-496-6828
SOURCE: Bohai Pharmaceuticals Group, Inc.
Associated Documentation:
Link to submission on http://www.eteligis.com BOPH_7-28-2014_LST_ETL.docx
Asia Ir-Pr Launches Bilingual English-Mandarin Blog; Invites Submissions From Analysts, Investors
NEW YORK, United States, via eTeligis Inc., 07/17/2014 - - Asia IR-PR, a new investor relations and public relations agency that specializes in representing U.S.-listed Chinese public companies, today announced it has initiated a bilingual English-Mandarin blog, Asia IR•PR Voice, focusing on developments with the agency’s clients and the industries they represent.
The blog, found at www.asia-irpr.com, currently features SinoCoking Coal and Coke Chemical Industries, Inc. (NasdaqCM: SCOK), a client building a facility for the large-scale production of syngas, a pollutant-free fuel used as an alternative for the burning of coal as well as for conversion into a wide range of commercial products including fertilizers, solvents, plastics, adhesives, paints and clothing.
Asia IR-PR also welcomes blog submissions of 500 words or less from analysts and investors who wish to comment on financial and economic factors influencing business growth in China, particularly in the clean energy, pharmaceutical, automotive and microcredit industries.
Submissions for consideration may be sent to Asia IR-PR president, Ron Altbach, at
Based in New York City, Asia IR-PR helps undervalued China-based public companies optimize communications with financial industry and media professionals and achieve stock valuations correlated with these companies’ actual performance. The agency provides services in six primary areas: investor relations, media relations, corporate communications, social media, capital formation, and business advisory.
In addition to SinoCoking Coal and Coke Chemical Industries, Asia IR-PR’s current client list includes:
-Bohai Pharmaceuticals Group, Inc., a manufacturer and marketer of traditional Chinese medicine (TCM) in the People’s Republic of China;
- CAA Resources Limited, a rapidly growing iron ore product company mining and selling high-quality mineral products to leading steel manufacturers in the Peoples Republic of China;
-China Commercial Credit, Inc., a microfinance company providing financial services to small-to-medium enterprises (SMEs), farmers and individuals in Jiangsu Province, China;
-Lentuo International, a leading non-state-owned automobile retailer headquartered in Beijing; and
-NQ Mobile Inc., a leading global provider of mobile Internet services.
About Asia IR-PR
Founded in 2013, Asia IR-PR is a full-service IR/PR/Media company formed specifically to develop comprehensive communications programs for Asia-based public companies listed on NASDAQ, NYSE, and the HKSE. The principals of Asia IR-PR, with decades of experience in the public markets, have managed and successfully conducted both IR and PR campaigns for over 100 U.S.-listed companies. Based in New York City, ASIA IR-PR has in-house analysts and executives fluent in both Mandarin and English in order to best communicate with Chinese management of our listed client companies.
ASIA IR•PR
A Division of Perceptive Programs, LLC
156 W 56th Street, Suite 702
New York, NY 10019
(212) 616-8082
www.asia-irpr.com
Companies wishing to discuss representation with Asia IR-PR should contact:
Ron Altbach at [email protected].
Additional Contacts:
Investors Media
Jimmy Caplan Rick Eisenberg
512-329-9505 212-496-6828
Associated Documentation:
Link to submission on http://www.eteligis.com Asia_IR-PR_7-17-2014_ALD_ETL.docx
今日のphaseone wikipedia
本日ピックアップしたいニュースは、phaseone wikipediaについてです。Investigating the cosmos at CSU - Rocky Mountain Collegian
Investigating the cosmos at CSU Rocky Mountain Collegian The collaboration, known as the Long-Baseline Neutrino Experiment, will attempt to answer this question and many others over the next 30 years. Phase one of the project is projected to cost $900 million alone, and is funded by the US Department of Energy.
中判のデジカメってありますか? 中判のデジカメってありますか? 中判デジカメを買いたいと思っています。 あるいは、フィルム式中判カメラを 中判デジカメに変更できる部品 ( CCD ) みたいなものでもかまいません。 特...
さらには
Marvel Cinematic Universe - Phase One: Avengers Assembled Box Set Trailer
楽天市場
《新品》 PHASE ONE(フェイズワン) IQ250((PhaseOne645/Mamiya 645AFD専用) 5年保証価格: 5,400,000円 レビュー評価:0.0 レビュー数:0種別:デジタルカメラアクセサリー NOTE多岐にわたる撮影に対応IQ250はより幅広いイメージを実現するための新しいスタイルです。5000万画素の究極のイメージクオリティがISO100から6400で実現、滑らかで高反応なライブビューで快適に確認でき、 より広い範囲でのフォトグラフィックチャレンジを実現する新しい製品です。■主な特徴驚異的な感度性能ISO100から6400までの高いクオリティを実現します。どんな光源でもユニークなイメージ撮影が可能です。滑らかで高反応なライブビューIQ250の滑らかで高反応なライブビューで表示、デジタルバック上でもUSB3経由のCapture OneやワイヤレスでCapture Pilot(フォトアプリ)でも容易に構図、ピント確認ができます。5000万画素キャプチャー撮影画像は驚愕の5000万画素を誇ります。14 f-stopダイナミックレンジ最も要求度の高い被写体でも14 f-stop のダイナミックレンジによりハイライト、シャドウのディテールを維持し捉えることが可能です。1時間以上の長時間露光IQ250の露光時間は驚異的です。 1/10000から1時間に及ぶ時間を誇ります。 (添付のカメラの場合は露光時間に限界があります。)■主な仕様レンズファクター :1.3CCD size effective (mm) :44.0 x 33.0アクティブピクセル :8280 x 6208ピクセルサイズ (ミクロン) :5.3 x 5.3リソリューション (メガピクセル) :50ISO感度 :100 - 6400露光時間 :1/10000s - 60 min.イメージの画質 :13 f-stops露光時間 (フレーム/毎秒) :1.2イメージバッファー :2 Gb advanced high speed RAMディスプレイ :3.2インチのレティナタイプのマルチタッチスクリーン115万画素229ppi1600万色170度のビューイングアングル<!